L-Carnitine ameliorates the liver by regulating alpha-SMA, iNOS, HSP90, HIF-1alpha, and RIP1 expressions of CCL4-toxic rats

Document Type : Original Article

Authors

1 Department of Histology-Embryology, Faculty of Medicine, Erciyes University, Kayseri, Turkey

2 Department of Biology, Faculty of Science, Erciyes University, Kayseri, Turkey

3 Department of Biochemistry, Faculty of Medicine, Erciyes University, Kayseri, Turkey

4 Department of Pathology, Faculty of Veterinary, Erciyes University, Kayseri, Turkey

Abstract

Objective(s): Carbon tetrachloride (CCL4) toxicity triggers fibrosis, activating various mechanisms within the cell. We aimed to create damage with CCL4 and investigate the effectiveness of L-carnitine on the mechanisms we identified.
Materials and Methods: Forty rats were divided into 5 groups with equal number of rats in each group. Group I: Control group, Group II: L-carnitine group, 200 mg/kg L-carnitine twice a week, Group III: CCL4 group, 0.2 ml/100 gr CCL4, IP, dissolved in olive oil 2 times a week during 6 weeks; Group IV: L-carnitine + CCL4 group, 200 mg/kg L-carnitine 24 hr before 0.2 ml/100 g CCL4 application twice a week; Group V: CCL4 + L-carnitine, 200 mg/kg L-carnitine half an hour after 0.2 ml/100 g CCL4 application. The liver was evaluated histologically. Immunohistochemically stained with α-SMA, iNOS, HSP90, HIF-1α, and RIP1. TNF-α, TGF-β, AST, ALT, ALP, and GGT measurements were evaluated.  
Results: In the classical lobule periphery, an increase in lipid accumulation and a decrease in glycogen accumulation were observed. After immunohistochemical measurements and biochemical analyzes, an increase in the expression density of all proteins was observed in group III. In group IV and V, an improvement in tissue and a decrease in protein expression densities were observed.
Conclusion: iNOS serves as a free radical scavenger in response to damage caused by increased toxicity of α-SMA, HSP90, and HIF-1α. Especially, increased RIP1 level in the tissue indicates the presence of necrosis in the tissue after CCL4-toxicity. Supplementing the amount of endogenous L-carnitine with supplementation provides a significant improvement in the tissue.

Keywords

References

1. Robert S, Gicquel T, Victoni T, Valenca S, Barreto E, Bailly-Maitre B, et al. Involvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosis. Biosci Rep 2016; 36: e00360.
2. Sonsuz A. Karaciger Sirozunun Etyolojisi ve Patogenezi. Hepato-Bilier Sistem ve Pankreas Hastalıkları Sempozyum Dizisi 2002; 28:87-91.
3. Ramadori G, Moriconi F, Malik I, Dudas J. Physiology and pathophysiology of liver inflammation, damage and repair. J Physiol Pharmacol 2008; 59 Suppl 1:107-117.
4. Roth KJ, Copple BL. Role of hypoxia-inducible factors in the development of liver fibrosis. Cell Mol Gastroenterol Hepatol 2015; 1:589-597.
5. Gao J, Qin XJ, Jiang H, Chen JF, Wang T, Zhang T, et al. Detecting serum and urine metabolic profile changes of CCl4-liver fibrosis in rats at 12 weeks based on gas chromatography-mass spectrometry. Exp Ther Med 2017; 14:1496-1504.
6. Ali SA, Faddah L, Abdel-Baky A, Bayoumi A. Protective effect of L-carnitine and coenzyme Q10 on CCl(4)-induced liver injury in rats. Sci Pharm 2010; 78:881-896.
7. Zheng Z, Gelling RW. Attenuation of carbon tetrachloride-induced hepatic toxicity by a dietary supplement. J Diet Suppl 2017; 14:121-131.
8. Annadurai T, Vigneshwari S, Thirukumaran R, Thomas PA, Geraldine P. Acetyl-L-carnitine prevents carbon tetrachloride-induced oxidative stress in various tissues of Wistar rats. J Physiol Biochem 2011; 67:519-530.
9. Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev 2017; 121:27-42.
10. Brenner DA, Kisseleva T, Scholten D, Paik YH, Iwaisako K, Inokuchi S, et al. Origin of myofibroblasts in liver fibrosis. Fibrogenesis Tissue Repair 2012; 5:S17.
11. Kılınç A, Oksit KKN. Biyolojik Fonksiyonları ve Toksik Etkileri. Ankara: Palme Yayıncılık 2003:1-50-59.
12. Dixit VD, Parvizi N. Nitric oxide and the control of reproduction. Anim Reprod Sci 2001; 65:1-16.
13. Wang C, Zhang Y, Guo K, Wang N, Jin H, Liu Y, et al. Heat shock proteins in hepatocellular carcinoma: Molecular mechanism and therapeutic potential. Int J Cancer 2016; 138:1824-1834.
14. Yu X, Mao M, Liu X, Shen T, Li T, Yu H, et al. A cytosolic heat shock protein 90 and co-chaperone p23 complex activates RIPK3/MLKL during necroptosis of endothelial cells in acute respiratory distress syndrome. J Mol Med (Berl) 2020; 98:569-583.
15. Moon JO, Welch TP, Gonzalez FJ, Copple BL. Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice. Am J Physiol Gastrointest Liver Physiol 2009; 296:G582-592.
16. Harmeyer J. The physiological role of L-carnitine. Lohman Information 2002; 27:15-21.
17. Zhou X, Liu F, Zhai S. Effect of L-carnitine and/or L-acetyl-carnitine in nutrition treatment for male infertility: a systematic review. Asia Pac J Clin Nutr 2007; 16 Suppl 1:383-390.
18. Çekın AH, Gür G, Türkoğlu S, Aldemır D, Yilmaz U, Gürsoy M, et al. The protective effect of L-carnitine on hepatic ischemia-reperfusion injury in rats. Turk J Gastroenterol 2013; 24:51-56.
19. Li Y, Yang H. [Effect of interferon-α on rat liver fibrosis induced by CCl(4)]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2011; 36:243-248.
20. Sayan M, Karabulut D, Özdamar S. Assessment of the protective and therapeutic effect of melatonin against thioacetamide‐induced acute liver damage. J Biochem Mol Toxicol 2020; 34:e22450.
21. Karabulut D, Sonmez MF. Effects of diabetes on nitric oxide synthase in rat uterus. Biotech Histochem 2020:1-8.
22. Sharma A, Nagalli S. Chronic liver disease. StatPearls. Treasure Island (FL): StatPearls Publishing StatPearls Publishing LLC.; 2020.
23. Movassaghi S, Sharifi ZN, Mohammadzadeh F, Soleimani M. Pentoxifylline protects the rat liver against fibrosis and apoptosis induced by acute administration of 3, 4-methylenedioxymethamphetamine (MDMA or ecstasy). Iranian journal of basic medical sciences 2013; 16:922.
24. Chamulitrat W, Blazka ME, Jordan SJ, Luster MI, Mason RP. Tumor necrosis factor-alpha and nitric oxide production in endotoxin-primed rats administered carbon tetrachloride. Life Sci 1995; 57:2273-2280.
25. Devaraj E, Roy A, Royapuram Veeraragavan G, Magesh A, Varikalam Sleeba A, Arivarasu L, et al. beta-Sitosterol attenuates carbon tetrachloride-induced oxidative stress and chronic liver injury in rats. Naunyn Schmiedebergs Arch Pharmacol 2020.
26. Phan SH. Biology of fibroblasts and myofibroblasts. Proc Am Thorac Soc 2008; 5:334-337.
27. Eltahir HM, Fawzy MA, Mohamed EM, Alrehany MA, Shehata AM, Abouzied MM. Antioxidant, anti-inflammatory and anti-fibrotic effects of Boswellia serrate gum resin in CCl4-induced hepatotoxicity. Exp Ther Med 2020; 19:1313-1321.
28. Moreno MG, Muriel P. Inducible nitric oxide synthase is not essential for the development of fibrosis and liver damage induced by CCl4 in mice. J Appl Toxicol 2006; 26:326-332.
29. Oleshchuk O, Ivankiv Y, Falfushynska H, Mudra A, Lisnychuk N. Hepatoprotective effect of melatonin in toxic liver injury in rats. Medicina (Kaunas) 2019; 55:304-314.
30. Lee KJ, Terada K, Oyadomari S, Inomata Y, Mori M, Gotoh T. Induction of molecular chaperones in carbon tetrachloride-treated rat liver: implications in protection against liver damage. Cell Stress Chaperones 2004; 9:58-68.
31. Bozova S, Elpek GO. Hypoxia-inducible factor-1alpha expression in experimental cirrhosis: correlation with vascular endothelial growth factor expression and angiogenesis. APMIS 2007;115:795-801.
32. Jacobsen AV, Silke J. The importance of being chaperoned: HSP90 and necroptosis. Cell Chem Biol 2016; 23:205-207.
33. Li D, Xu T, Cao Y, Wang H, Li L, Chen S, et al. A cytosolic heat shock protein 90 and cochaperone CDC37 complex is required for RIP3 activation during necroptosis. Proc Natl Acad Sci U S A 2015; 112:5017-5022.
34. Demiroren K, Dogan Y, Kocamaz H, Ozercan IH, Ilhan S, Ustundag B, et al. Protective effects of L-carnitine, N-acetylcysteine and genistein in an experimental model of liver fibrosis. Clin Res Hepatol Gastroenterol 2014; 38:63-72.
35. Ozsoy SY, Ozsoy B, Ozyildiz Z, Aytekin I. Protective effect of L-carnitine on experimental lead toxicity in rats: a clinical, histopathological and immunohistochemical study. Biotech Histochem 2011; 86:436-443.
36. Cetinkaya A, Kantarceken B, Bulbuloglu E, Kurutas EB, Ciralik H, Atli Y. The effects of L-carnitine and N-acetylcysteine on carbontetrachloride induced acute liver damage in rats. Bratisl Lek Listy 2013; 114:682-688.
37. Sharma S, Sun X, Agarwal S, Rafikov R, Dasarathy S, Kumar S, et al. Role of carnitine acetyl transferase in regulation of nitric oxide signaling in pulmonary arterial endothelial cells. Int J Mol Sci 2012; 14:255-272.
38. Copple BL, Bustamante JJ, Welch TP, Kim ND, Moon JO. Hypoxia-inducible factor-dependent production of profibrotic mediators by hypoxic hepatocytes. Liver Int 2009; 29:1010-1021.
39. Gulcin I. Antioxidant and antiradical activities of L-carnitine. Life Sci 2006; 78:803-811.
Iranian Journal of Basic Medical Sciences
Volume 24, Issue 2
February 2021
Pages 184-190

Files

Share

How to cite

Statistics